IV4X

IV4X is a forex and CFD broker registered in South Africa, with its official domain at iv4x.com. The company was founded on March 4, 2022, and is based at 2nd floor, Nelson Mandela Square, Maude St, Sandton, 2146. As a relatively new entrant, IV4X aims to provide trading services across multiple asset classes.

According to our records, the broker operates with a limited public presence. No independent user reviews are available, and aggregated industry data is sparse. This lack of external validation makes it challenging to assess the broker's reputation and operational history.

IV4X currently holds no regulatory licences from any known financial authority. Our cross-check of public registers indicates no oversight from major regulators such as the FCA, CySEC, ASIC, or the FSCA (South Africa's financial regulator). This absence of regulation is a significant concern for trader protection.

Without regulatory oversight, clients have no recourse to compensation schemes or formal dispute resolution. The FXCanary Scam Risk Score for IV4X stands at 75 out of 100, indicating a severe risk. Traders should exercise extreme caution, especially when depositing funds with an unregulated entity.

IV4X offers three account tiers designed to cater to different trader profiles. The Standard account has a minimum deposit of $25 and maximum leverage of 1:500, making it accessible for beginners. The 100% Bonus account requires a $100 minimum deposit and also offers 1:500 leverage, with the promise of a bonus on deposits.

The Razor account is aimed at more experienced traders, with a high minimum deposit of $1000 and the same maximum leverage of 1:500. It likely features tighter spreads or lower commissions, though specific details are not publicly available. All accounts share the same maximum leverage, which is aggressive and can amplify both gains and losses.

IV4X provides trading in Forex, Shares, Indices, and Cryptocurrencies. This multi-asset offering allows traders to diversify within a single account. Forex trading typically includes major, minor, and exotic pairs, while Shares and Indices cover global equities and benchmarks.

Cryptocurrency trading is also available, which may appeal to those seeking exposure to digital assets. The broker does not disclose the number of instruments or specific contract specifications on its website, leading to a lack of transparency. Traders should verify instrument availability and conditions before committing funds.

The trading platform(s) offered by IV4X are not specified in the available records. Common platforms in the industry include MetaTrader 4, MetaTrader 5, or proprietary web-based solutions. Without this information, traders cannot confirm if their preferred platform is supported.

Given the broker's recent establishment and limited online footprint, it is advisable to contact customer support for platform details. The absence of platform information in our records adds to the overall uncertainty surrounding this broker's operations.

Details regarding customer support channels, such as live chat, email, or phone, are not publicly known. Similarly, deposit and withdrawal methods are not disclosed. This lack of information hinders a trader's ability to assess accessibility and convenience.

IV4X's website may provide these details, but as our review could not verify the site's content, we recommend traders seek direct clarification. In an unregulated environment, clear communication and transparent policies are even more critical.

IV4X is a young forex and CFD broker based in South Africa with no regulatory oversight. It offers a range of account types and instruments but lacks transparency in key areas such as platform, fees, and customer support. The high leverage of 1:500 across all accounts is a double-edged sword.

Given the severe risk score and absence of regulation, IV4X is not suitable for risk-averse traders or those seeking a secure trading environment. Only experienced traders fully aware of the risks should consider this broker, and even then, with limited capital. The lack of independent reviews and regulatory safeguards makes it a high-risk choice.